Public Release Summary on the evaluation of the new active constituent polyoxin D zinc salt in the product Intervene WG Fungicide

This consultation closed on 24 August 2021.
Consultation period: 
27 July 2021 to 24 August 2021

The Australian Pesticides and Veterinary Medicines Authority (APVMA) is considering an application for approval of the new active constituent polyoxin D zinc salt and registration of the product Intervene WG Fungicide, containing 113 g/kg polyoxin D zinc salt, as a water-dispersible granule (WG) formulation. The product is intended for the control of grey mould/botrytis rot and powdery mildew in berries and grapes and alternaria leaf spot and fruit spot, and powdery mildew in apples.  

We invite comment from 27 July 2021 to 24 August 2021 on whether approval of the active constituent and registration of the product should be granted.

The APVMA is able to consider comments relating to the legislative grounds, including:

  • occupational health and safety
  • public health
  • chemistry and manufacture
  • residues in food
  • environmental safety
  • trade
  • efficacy and target crop safety.

Download the Public Release Summary on the evaluation of Intervene WG Fungicide.

For more information see page 30, APVMA Gazette No. 15, 27 July 2021.

Please note: Submissions will be published on the APVMA’s website, unless you have asked for the submission to remain confidential (see public submission coversheet).

Please lodge your submission with a public submission coversheet, which provides options for how your submission will be published.

Note that all APVMA documents are subject to the access provisions of the Freedom of Information Act 1982 and may be required to be released under that Act should a request for access be made.

Please send your written submission and coversheet by email or post to:

Email: enquiries@apvma.gov.au

Post:

Case Management and Administration Unit
Australian Pesticides and Veterinary Medicines Authority
GPO Box 3262
Sydney NSW 2001

Your feedback will be submitted to the APVMA anonymously. If you require a response, please contact us.